Song, K., Niederst, M. J., Lochmann, T. L., Hata, A. N., Kitai, H., Ham, J., . . . Faber, A. C. (2017). Epithelial-to-mesenchymal transition antagonizes response to targeted therapies in lung cancer by suppressing BIM. Clin Cancer Res.
Citação norma ChicagoSong, Kyung-A, et al. "Epithelial-to-mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer By Suppressing BIM." Clin Cancer Res 2017.
MLA引文Song, Kyung-A, et al. "Epithelial-to-mesenchymal Transition Antagonizes Response to Targeted Therapies in Lung Cancer By Suppressing BIM." Clin Cancer Res 2017.
警告:這些引文格式不一定是100%准確.